Bibliografia

  • Bibliografia

    • Laura van 't Veer et al., Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002), 415: 530-535.
    • Marc van de Vijver et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009
    • Britta Weigelt et al., Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer, Cancer Res 2005; 65(20): 9155-8.
    • Susan Cleator et al. Molecular profiling of breast cancer: clinical implications, British Journal of Cancer (2004) 90, 1120 – 1124.
    • John Quakenbusch. Microarray analyis and tumor classification, N Engl J Med 2006;354:2463-72.
    • John Erban et al., On the toxicity of chemotherapy for breast cancer – the need for vigilance. Journal of the National Cancer Institute (2006), 98: 1096-1097.
    • Micheal Hassett et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. Journal of the National Cancer Institute (2006), 98: 1108-1117.
    • Marc Buyse et al., Validation and clinical utility of a 70-gene prognostic signature for women with a node-negative breast cancer, Journal of the National Cancer Institute (2006), 98: 1183-1192.
    • Annuska Glas et al., Converting a breast cancer microarray signature into a high-throughput diagnostic test, BioMed Central Genomics (2006), 278: 2164-2167.
Ferrer inCode  |  Diagonal, 549 5ª planta, E-08029 Barcelona  |  Tel. +34 93 600 37 00  |  Fax: +34 93 490 70 78